Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Vet Res ; 78(11): 1264-1272, 2017 Nov.
Article in English | MEDLINE | ID: mdl-29076366

ABSTRACT

OBJECTIVE To determine effects of transforming growth factor (TGF)-ß and interleukin (IL)-1ß on inflammatory markers in cultured canine chondrocytes to clarify the role of these cytokines in osteoarthritis of dogs. SAMPLE Pooled chondrocytes isolated from the stifle joints of 4 adult dogs. PROCEDURES Chondrocytes were isolated, cultured, and frozen at -80°C. Pooled cells were incubated in medium with or without TGF-ß (1 or 10 ng/mL) and subsequently stimulated with IL-1ß (10 ng/mL). Concentrations of nitric oxide (NO) and prostaglandin (PG) E were measured in culture supernatants. Gene expression of matrix metalloproteinase (MMP)-3, tissue inhibitor of metalloproteinase (TIMP)-2, inducible NO synthase (iNOS), and cyclooxygenase (COX)-2 was quantified by use of real-time quantitative PCR assays. RESULTS Stimulation with IL-1ß increased gene expression of all inflammatory markers, except for TIMP-2. Incubation with TGF-ß resulted in a significant decrease in MMP-3 and TIMP-2 mRNA concentrations but had no effect on PGE and NO concentrations. For cells treated with TGF-ß followed by IL-1ß, concentrations of PGE and NO were lower, compared with concentrations for IL-1ß control cells. Furthermore, IL-1ß-induced gene expression of iNOS, MMP-3, and COX-2 was downregulated. However, the IL-1ß-induced downregulation of TIMP-2 gene expression was partially restored by pretreatment with TGF-ß. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that IL-1ß increased the expression of inflammatory genes and mediators, and TGF-ß largely attenuated the IL-1ß-mediated inflammatory response. Therefore, TGF-ß might be a novel target for use in the prevention and treatment of cartilage breakdown in dogs with osteoarthritis.


Subject(s)
Chondrocytes/drug effects , Dog Diseases/drug therapy , Interleukin-1beta/pharmacology , Osteoarthritis/veterinary , Transforming Growth Factor beta/pharmacology , Animals , Cartilage/metabolism , Cells, Cultured , Chondrocytes/metabolism , Cyclooxygenase 2/metabolism , Dog Diseases/genetics , Dogs , Gene Expression , Inflammation Mediators/metabolism , Interleukin-1beta/genetics , Matrix Metalloproteinase 3/genetics , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/genetics , Osteoarthritis/drug therapy , Osteoarthritis/metabolism , Tissue Inhibitor of Metalloproteinase-2/genetics , Transforming Growth Factor beta/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...